Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 636

Results For "GE"

8420 News Found

Novartis Cosentyx receives positive CHMP opinion for use in childhood arthritic conditions
Biotech | May 21, 2022

Novartis Cosentyx receives positive CHMP opinion for use in childhood arthritic conditions

Positive opinion could expand the role of Cosentyx (secukinumab) in reducing flare risk in pediatric enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) patients in the EU


AbbVie submits NDA for treatment of advanced Parkinson’s disease
Biotech | May 21, 2022

AbbVie submits NDA for treatment of advanced Parkinson’s disease

If approved, ABBV-951 will offer patients the first continuous subcutaneous delivery of carbidopa/levodopa prodrugs


Aarogya Pay to make healthcare accessible for patients
Healthcare | May 21, 2022

Aarogya Pay to make healthcare accessible for patients

As part of Aarogya Pay, QR codes will be installed at doctors’ clinics that patients can scan to avail instant medical loans at 0% interest and 3/6 EMIs.


Medical students to learn key medical skills and other patient diagnosis in VR
News | May 21, 2022

Medical students to learn key medical skills and other patient diagnosis in VR

The new lab is a testament to the Pondicherry Institute of Medical Sciences (PIMS)’s long-held values and traditions of striving for excellence and embracing newer innovations in order to deliver the best standard of training for their students


Havas Health & You appoints Dan Rubin as President of Havas Health +
People | May 20, 2022

Havas Health & You appoints Dan Rubin as President of Havas Health +

Key senior hire will partner with Allison Ceraso, President and CCO, bolstering agency leadership amongst continued network momentum


Bristol Myers Squibb highlights progress in treatment for cancer and blood disorders
Biotech | May 20, 2022

Bristol Myers Squibb highlights progress in treatment for cancer and blood disorders

First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm


Propanc Biopharma undertaking PRP manufacturing & development for human use
Biotech | May 20, 2022

Propanc Biopharma undertaking PRP manufacturing & development for human use

PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection


Sparsh Hospital introduces ‘Infinite care’ joint replacement programme
Hospitals | May 20, 2022

Sparsh Hospital introduces ‘Infinite care’ joint replacement programme

‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema


Pharma companies with ESG more valuable say investors
Sustainability | May 20, 2022

Pharma companies with ESG more valuable say investors

When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’


Glenmark receives sANDA approval for Abiraterone Acetate tablets
Drug Approval | May 20, 2022

Glenmark receives sANDA approval for Abiraterone Acetate tablets

According to IQVIA sales data for the 12-month period ending March 2022, the Zytiga tablets, 500 mg market achieved annual sales of approximately US $ 260.2 million